Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Expert Review of Endocrinology and Metabolism is Scopus-indexed (Q2, CiteScore 5.5), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1744-6651Verify ISSN ↗1744-8417Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 93 / 250 | 63rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q2, CiteScore 5.5.
Expert Review of Endocrinology and Metabolism is Q2 in Endocrinology, Diabetes and Metabolism (rank 93 of 250), by CiteScore 2025.
Expert Review of Endocrinology and Metabolism is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.5, which places it in quartile Q2 at the 63rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.107, quartile Q2, with an H-index of 41.
Expert Review of Endocrinology and Metabolism is published by Taylor and Francis Ltd. Its print ISSN is 1744-6651 and its online ISSN is 1744-8417.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Expert Review of Endocrinology and Metabolism has an h-index of 48 and a 2-year mean of 3.4 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q2. On 2-year citations it ranks #69 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Expert Review of Endocrinology and Metabolism published 61 papers in 2025; its busiest recent year was 2023 with 65. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from United States (16.2%), Italy (12.3%) and United Kingdom (9.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (2.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.